Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitesh Pandya

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Plos One|November 9, 2020
Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine studyHilary Siddall, Diana Quint, Hitesh Pandya, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 9, 2009
Extracorporeal membrane oxygenation for refractory septic shock in children: One institution's experienceMike Tembo, Christopher Harvey, Mark Duthie, et al.
Archives of Disease in Childhood|February 2, 2012
Specific antibody deficiency in children with chronic wet coughMichael Teik Chung Lim, Kayathrie Jeyarajah, Philippa Jones, et al.
Pediatric Research|December 8, 2016
Moderate hyperoxia induces extracellular matrix remodeling by human fetal airway smooth muscle cellsElizabeth R Vogel, Rodney D Britt, Arij Faksh, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 14, 2009
Extracorporeal membrane oxygenation and term neonatal respiratory failure deaths in the United Kingdom compared with the United States: 1999 to 2005Kate L Brown, Sudhir Sriram, Deborah Ridout, et al.
Clinical Therapeutics|December 4, 2025
Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a SpacerHitesh Pandya, Mehul Patel, Michael Gillen, et al.
The Lancet. Respiratory Medicine|September 13, 2014
Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trialChinedu Nwokoro, Hitesh Pandya, Stephen Turner, et al.
Bioanalysis|December 22, 2011
Use of dried blood spots to study excipient kinetics in neonatesShirish Yakkundi, James McElnay, Jeff Millership, et al.
British Journal of Clinical Pharmacology|August 26, 2024
Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary diseaseMuhammad Waqas Sadiq, Hongtao Yu, Magnus Åstrand, et al.
Clinical Pharmacology in Drug Development|March 25, 2024
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese ParticipantsYunfei Li, Hua Zhang, Hitesh Pandya, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Plos One|November 9, 2020
Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine studyHilary Siddall, Diana Quint, Hitesh Pandya, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 9, 2009
Extracorporeal membrane oxygenation for refractory septic shock in children: One institution's experienceMike Tembo, Christopher Harvey, Mark Duthie, et al.
Archives of Disease in Childhood|February 2, 2012
Specific antibody deficiency in children with chronic wet coughMichael Teik Chung Lim, Kayathrie Jeyarajah, Philippa Jones, et al.
Pediatric Research|December 8, 2016
Moderate hyperoxia induces extracellular matrix remodeling by human fetal airway smooth muscle cellsElizabeth R Vogel, Rodney D Britt, Arij Faksh, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 14, 2009
Extracorporeal membrane oxygenation and term neonatal respiratory failure deaths in the United Kingdom compared with the United States: 1999 to 2005Kate L Brown, Sudhir Sriram, Deborah Ridout, et al.
Clinical Therapeutics|December 4, 2025
Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a SpacerHitesh Pandya, Mehul Patel, Michael Gillen, et al.
The Lancet. Respiratory Medicine|September 13, 2014
Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trialChinedu Nwokoro, Hitesh Pandya, Stephen Turner, et al.
Bioanalysis|December 22, 2011
Use of dried blood spots to study excipient kinetics in neonatesShirish Yakkundi, James McElnay, Jeff Millership, et al.
British Journal of Clinical Pharmacology|August 26, 2024
Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary diseaseMuhammad Waqas Sadiq, Hongtao Yu, Magnus Åstrand, et al.
Clinical Pharmacology in Drug Development|March 25, 2024
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese ParticipantsYunfei Li, Hua Zhang, Hitesh Pandya, et al.
Pageof 3